Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lung Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03958565
What this trial is testing

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University of Colorado, Denver 100
Not applicableStudy completedNCT02616211
What this trial is testing

An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors

Who this might be right for
Adenocarcinoma of LungLung NeoplasmCancer of Lung+4 more
Mayo Clinic 15
Not applicableStudy completedNCT03746392
What this trial is testing

Project to Improve Communication About Serious Illness - Pilot Study

Who this might be right for
Malignant NeoplasmLeukemia, Lymphocytic, Chronic, B-CellLung Disease Chronic+7 more
University of Washington 150
Not applicableEnded earlyNCT00748085
What this trial is testing

CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)

Who this might be right for
Lung CancerMesothelioma
CSA Medical, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT02497508
What this trial is testing

Nivolumab in Patients With Recurrent Malignant Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
The Netherlands Cancer Institute 33
Not applicableStudy completedNCT05640765
What this trial is testing

BeWell360-CG Care Model: Health and Wellness Coaching to Support Caregivers of Patients Living With Advanced Lung Cancers

Who this might be right for
Advanced Lung CarcinomaStage III Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8
Mayo Clinic 55
Testing effectiveness (Phase 2)Ended earlyNCT02459067
What this trial is testing

ImmuniCell® in Patients With Advanced Cancers

Who this might be right for
Malignant MelanomaNon-small Cell Lung CancerRenal Cell Cancer
TC Biopharm 8
Large-scale testing (Phase 3)Study completedNCT00347412
What this trial is testing

Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Cellectar Biosciences, Inc. 903
Not applicableStudy completedNCT00897247
What this trial is testing

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite

Who this might be right for
Malignant MesotheliomaPulmonary Complications
Barbara Ann Karmanos Cancer Institute 494
Not applicableWithdrawnNCT06494046
What this trial is testing

Defining Musical Toxicity and Its Effect on Patient Well-being

Who this might be right for
Breast CarcinomaEsophageal CarcinomaHead and Neck Carcinoma+3 more
Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Looking for participantsNCT06251310
What this trial is testing

SW-682 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMesothelioma, Malignant
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 186
Not applicableActive Not RecruitingNCT04607590
What this trial is testing

Yoga Program for Improving the Quality of Life in Couples Coping With Cancer

Who this might be right for
Esophageal CarcinomaLung CarcinomaMalignant Head and Neck Neoplasm+1 more
M.D. Anderson Cancer Center 600
Testing effectiveness (Phase 2)Ended earlyNCT05860296
What this trial is testing

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

Who this might be right for
Lung Cancer, Nonsmall CellLung Cancer Stage IVLung Cancer Metastatic
SignalChem Lifesciences Corporation 36
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Not applicableUnknownNCT05414188
What this trial is testing

Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation Therapy

Who this might be right for
Lung Neoplasm Malignant
Asan Medical Center 70
Early research (Phase 1)Active Not RecruitingNCT03228537
What this trial is testing

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaStage I Pleural Diffuse Malignant Mesothelioma AJCC v7+4 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT00171912
What this trial is testing

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Who this might be right for
Hypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more
Novartis Pharmaceuticals 38
Not applicableEnded earlyNCT01851395
What this trial is testing

Rapid Autopsy and Procurement of Cancer Tissue

Who this might be right for
Thymus TumorsAdoptive Cellular TherapyMesothelioma+2 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT03698994
What this trial is testing

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Ependymal TumorRecurrent Ewing Sarcoma+33 more
National Cancer Institute (NCI) 20
Next Page